HBsAg阳性孕产妇分娩儿童早期体格发育与疾病分析
本研究为回顾性队列研究,在浙江省三个地区采用分层整群抽样,纳入2014年HBsAg阳性孕产妇分娩儿童(暴露组)与1∶1配对非HBV感染孕产妇分娩儿童(对照组)各342例,比较出生及6、9、12、18月龄体格发育与疾病发生。结果显示两组低出生体重、早产及多数生长指标无显著差异,但对照组出生体重和18月龄头围高于暴露组;暴露组儿童全部接种三剂乙肝疫苗,免疫球蛋白接种率98.8%,18月龄母婴传播率1.0%。结论认为两组早期体格发育与疾病发生无明显差异。
要点
- 暴露组与对照组低出生体重检出率分别为1.8%(6/342)与2.6%(9/342),差异无统计学意义(P=0.433)。
- 对照组出生体重(3.4±0.4)kg高于暴露组(3.3±0.4)kg(P=0.019)。
- 对照组18月龄头围(47.3±1.3)cm高于暴露组(47.0±2.0)cm(P=0.038)。
核心结论
- HBsAg阳性孕产妇分娩儿童早期体格发育与疾病发生与对照组无明显差异。
研究设计与样本
- 本研究为回顾性队列研究,采用分层整群抽样选择浙江省杭州西湖区、金华兰溪市和嘉兴海盐县3个研究现场。
- 2014年本地户籍HBsAg阳性孕产妇分娩儿童为暴露组,采用1∶1配对选择非乙型肝炎孕产妇分娩儿童为对照组,共342对。
- 比较两组儿童出生、6、9、12与18月龄体格发育与疾病发生差异。
主要发现
- 暴露组与对照组低出生体重检出率分别为1.8%(6/342)、2.6%(9/342)(P=0.433);早产检出率分别为2.3%(8/342)、2.0%(7/342)(P=0.794)。
- 对照组出生体重为(3.4±0.4)kg,高于暴露组[(3.3±0.4)kg](P=0.019)。
- 对照组18月龄头围为(47.3±1.3)cm,高于暴露组[(47.0±2.0)cm](P=0.038)。
- 两组儿童出生孕周,6、9、12和18月龄身长、体重,月均体重、身长、头围增长,年龄别体重、身长、头围Z评分,身长迟缓、低体重与疾病检出率差异均无统计学意义(P>0.05)。
- HBsAg阳性孕产妇分娩儿童全部接受三剂乙型肝炎疫苗注射,同时接受免疫球蛋白注射者占98.8%(338/342);满18月龄儿童乙型肝炎母婴传播率为1.0%(1/97)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To estimate the early physical growth and disease in children born to HBsAg-positive mothers. Methods: This was a retrospective cohort study. Three areas as Xihu in Hangzhou, Lanxi in Jinhua, and Haiyan in Jiaxing in Zhejiang province were selected by cluster sampling. The growth outcomes of children born to HBsAg-positive mothers (exposure group) and matched 1∶1 women uninfected with HBV (control group) in 2014 were investigated and compared at birth, 6, 9, 12, and 18 months, respectively. There were totally 342 children in each group. Results: The incidences of low birth weight (LBW) for children born to exposure and control group were 1.8% (6/342), and 2.6% (9/342), respectively (P=0.433); and, rates of preterm birth were 2.3% (8/342), and 2.0% (7/342), respectively (P=0.794). The mean birth weight of children born to mothers without HBV infection (3.4±0.4) kg was dramatically higher than children in exposure group (3.3±0.4) kg (P=0.019). At 18 months, the average head circumference was significantly greater among children in control group (47.3±1.3) cm than children in exposure group (47.0±2.0) cm (P=0.038). Additional, mean birth weeks, height, weight, increases in height/weight/head circumference each month, weight/height/head circumference for age Z scores, proportion of growth retardation and low weight, disease prevalence were not observed statistically differences between two groups (P>0.05). All children born to HBsAg-positive mothers were received three-dose HBV vaccination. The rate of hepatitis B immunoglobulin for births born to HBsAg-positive was 98.8% (338/342). Mother to children transmission of HBV at 18 months was 1.0% (1/97). Conclusion: No significant differences in growth development and disease prevalence were found among children born to HBsAg-positive women and women without HBV infection. 目的: 评估HBsAg阳性孕产妇分娩儿童早期体格发育与疾病情况。 方法: 本研究为回顾性队列研究。采用分层整群抽样选择浙江省杭州西湖区、金华兰溪市和嘉兴海盐县3个研究现场。2014年本地户籍HBsAg阳性孕产妇分娩儿童为暴露组,采用1∶1配对选择非乙型肝炎孕产妇分娩儿童为对照组,共342对。比较两组儿童出生、6、9、12与18月龄体格发育与疾病发生差异。 结果: 暴露组与对照组低出生体重检出率分别为1.8%(6/342)、2.6%(9/342)(P=0.433);早产检出率分别为2.3%(8/342)、2.0%(7/342)(P=0.794)。对照组出生体重为(3.4±0.4)kg,高于暴露组[(3.3±0.4)kg](P=0.019);对照组18月龄头围为(47.3±1.3)cm,高于暴露组[(47.0±2.0)cm](P=0.038)。两组儿童出生孕周,6、9、12和18月龄身长、体重,月均体重、身长、头围增长,年龄别体重、身长、头围Z评分,身长迟缓、低体重与疾病检出率差异均无统计学意义(P>0.05)。HBsAg阳性孕产妇分娩儿童全部接受三剂乙型肝炎疫苗注射,同时接受免疫球蛋白注射者占98.8%(338/342);满18月龄儿童乙型肝炎母婴传播率为1.0%(1/97)。 结论: HBsAg阳性孕产妇分娩儿童早期体格发育与疾病发生与对照组无明显差异。.
引用
- Zhang XH, Wang Q, Zheng W, et al. [Early physical growth and disease analysis among children born delivered by HBsAg-positive mothers]. Zhonghua Yu Fang Yi Xue Za Zhi. 2017. PMID: 28592092. doi:10.3760/cma.j.issn.0253-9624.2017.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。